1887

Abstract

Summary

Antibodies to were investigated in serum from cystic fibrosis (CF) patients by immunoblotting (Western blotting). The results were compared with determinations of precipitating antibodies in serum by crossed immune electrophoresis (CIE). The number of CIE precipitins is a sensitive and specific indication of infection and is used, with sputum bacteriology, to distinguish between colonisation and invasive lung infection. Immunoblotting was considerably more sensitive than CIE for detecting antibodies to Paired serum samples from 64 CF patients, taken before a diagnosis of lung infection and immediately afterwards, showed a marked increase in the number of serum antibodies with the onset of infection. The intensity of the reaction, as shown by the density of blotted bands, was also increased. Laser scanning densitometry of immunoblots, and of photographic negatives taken from them, was used to quantify the increases. Differences in the number and intensity of blotted bands were highly significant between the two groups. The reproducibility of the method was good. An immunoblot assay may be a sensitive and useful method for routine diagnosis of early lung infection in CF.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-27-3-169
1988-11-01
2024-07-15
Loading full text...

Full text loading...

/deliver/fulltext/jmm/27/3/medmicro-27-3-169.html?itemId=/content/journal/jmm/10.1099/00222615-27-3-169&mimeType=html&fmt=ahah

References

  1. Anwar H., Brown M. R. W., Day A., Weller P. H. 1984; Outer membrane antigens of mucoid Pseudomonas aeruginosa isolated directly from the sputum of a cystic fibrosis patient. FEMS Microbiology Letters 24:235–239
    [Google Scholar]
  2. Baltimore R. S., Fick R. B., Fino L. 1986; Antibody to multiple mucoid strains of Pseudomonas aeruginosa in patients with cystic fibrosis, measured by an enzynme-linked immunosorbent assay. Pediatric Research 20:1085–1090
    [Google Scholar]
  3. Brett M. M., Ghoneim A. T. M., Littlewood J. M. 1986; Serum antibodies to Pseudomonas aeruginosa in cystic fibrosis. Archives of Disease in Childhood 61:1114–1120
    [Google Scholar]
  4. Cowan S. T. 1974; Cowan and Steel’s Manual for the identification of medical bacteria. 2nd edn Cambridge University Press; Cambridge:
    [Google Scholar]
  5. Cryz S. R. 1984; Pseudomonas aeruginosa infections. In Germanier R. (ed) Bacterial vaccines Academic Press; London: p 317
    [Google Scholar]
  6. Dasgupta M. K. 1987; Combined evaluation of circulating immune complexes and antibodies to Pseudomonas aeruginosa as an immunologic profile in relation to pulmonary function in cystic fibrosis. Journal of Clinical Immunology 7:51–58
    [Google Scholar]
  7. Fernandes P. B., Kim C., Cundy K. R., Huang N. N. 1981; Antibodies to cell envelope proteins of Pseudomonas aeruginosa in cystic fibrosis patients. Infection and Immunity 33:527–532
    [Google Scholar]
  8. Fomsgaard A., Dinesen B. 1987; ELISA for human IgG and IgM anti-lipopolysaccharide antibodies with indirect standardization. Journal of Immunoassay 8:333–350
    [Google Scholar]
  9. Govan J. R. W., Harris G. S. 1986; Pseudomonas aeruginosa and cystic fibrosis: unusual bacterial adaptation and pathogenesis. Microbiological Sciences 3:302–308
    [Google Scholar]
  10. Granstrøm. 1984; Relation between antibody response to Pseudomonas aeruginosa exoproteins and colonization/infection in patients with cystic fibrosis. Acta Paediatrica Scandinavica 73:772–777
    [Google Scholar]
  11. Hancock R. E. W., Mouat E. C. A., Speert D. P. 1984; Quantitation and identification of antibodies to outer-membrane proteins of Pseudomonas aeruginosa in sera of patients with cystic fibrosis. Journal of Infectious Diseases 149:220–226
    [Google Scholar]
  12. Høiby N. 1975; Cross-reactions between Pseudomonas aeruginosa and thirty-six other bacterial species. Scandinavian Journal of Immunology 4: Suppl 2 187–196
    [Google Scholar]
  13. Høiby N. 1977a; Antibodies against Pseudomonas aeruginosa in sera from normal persons and from patients colonized with mucoid or non-mucoid Pseudomonas aeruginosa. Results obtained by means of crossed immunoelectrophoresis. Acta Pathologica et Microbiologica Scandinavica Section C 85:142–148
    [Google Scholar]
  14. Høiby N. 1977b; Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by crossed immunoelectrophoresis. A survey. Acta Pathologica et Microbiologica Scandinavica Section C Suppl. 262 3–96
    [Google Scholar]
  15. Høiby N., Flensborg E. W., Beck B., Friis B., Jacobsen S. V., Jacobsen L. 1977; Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. Scandinavian Journal of Respiratory Diseases 58:65–79
    [Google Scholar]
  16. Høiby N., Doring G., Schiotz P. O. 1987; Pathogenic mechanism of chronic Pseudomonas aeruginosa infections in cystic fibrosis patients. Antibiotics and Chemotherapy 39:60–76
    [Google Scholar]
  17. Mikkelsen O. S. 1970; Serotyping of Pseudomonas aeruginosa 2. Results of an O group classification. Acta Pathologica et Microbiologica Scandinavica Section B 78:163–175
    [Google Scholar]
  18. Moss R. B., Hsu Y. P., Lewiston N. J. 1981; 125I-Clq-binding and specific antibodies as indicators of pulmonary disease activity in cystic fibrosis. Journal of Pediatrics 99:215–222
    [Google Scholar]
  19. Pedersen S. S., Jensen T., Pressler T., Høiby N., Rosendal K. 1986; Does centralized treatment of cystic fibrosis increase the rick of Pseudomonas aeruginosa infection?. Acta Paediatrica Scandinavica 75:840–845
    [Google Scholar]
  20. Pedersen S. S., Jensen T., Høiby N., Koch C., Flensborg E. W. 1987a; Management of Pseudomonas aeruginosa lung infection in Danish cystic fibrosis patients. Acta Paediatrica Scandinvica 76:955–961
    [Google Scholar]
  21. Pedersen S. S., Espersen F., Høiby N. 1987b; Diagnosis of chronic Pseudomonas aeruginosa infection in cystic fibrosis by enzyme-linked immunosorbent assay. Journal of Clinical Microbiology 25:1830–1836
    [Google Scholar]
  22. Pier G. B. 1987; Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis. New England Journal of Medicine 317:793–798
    [Google Scholar]
  23. Shand G. H., Anwar H., Kadurugamuwa J., Brown M. R. W., Silverman S. H., Melling J. 1985; In vivo evidence that bacteria in urinary tract infection grow under iron-restricted conditions. Infection and Immunity 48:35–39
    [Google Scholar]
  24. Szaff M., Høiby N., Flensborg E. W. 1983; Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic P.seudomonas aeruginosa infection. Acta Paediatrica Scandinavica 72:651–657
    [Google Scholar]
  25. Towbin H., Staehelin T., Gordon J. 1979; Electrophoretic transfer proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proceedings of the National Academy of Sciences of the USA 76:4350–4354
    [Google Scholar]
  26. Towbin H., Gordon J. 1984; Immunoblotting and dot immunoblotting—current status and outlook. Journal of Immunological Methods 72:313–340
    [Google Scholar]
  27. Wood R. E., Boat T. F., Doershuk. 1976; Cystic Fibrosis. American Review of Respiratory Diseases 113:833–878
    [Google Scholar]
  28. Wulff H. R. 1981; Rational diagnosis and treatment: an introduction to clinical decision-making. Blackwell Scientific Publications Oxford:
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-27-3-169
Loading
/content/journal/jmm/10.1099/00222615-27-3-169
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error